SCHEMBL20118645

SCHEMBL20118645

CC/C=C(\C)C(=O)Nc1ccc(C(=N)NC(=O)OCC)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.42
RAB9A P51151 4/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.38
CASP3 P42574 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118486 0.85 CYP19A1 (0.40) CYP19A1RAB9AMAPTNPSR1SMN1; SMN2
SCHEMBL24763936 0.82 RAB9A (0.49) RAB9AMAPTNPSR1SMN1; SMN2GAA
SCHEMBL20118775 0.78 F2 (0.63)
SCHEMBL20118453 0.77 RAB9A (0.47) RAB9AMAPTNPSR1SMN1; SMN2GAA
SCHEMBL20118539 0.75 ADRB2 (0.40) CYP19A1MAPTSMN1; SMN2HPGDTSHR
SCHEMBL12560520 0.74 SMN1; SMN2 (0.54) RAB9ASMN1; SMN2NPC1HPGDMEN1
SCHEMBL20118526 0.73 LMNA (0.57) RAB9AMAPTNPSR1SMN1; SMN2NPC1
SCHEMBL10523697 0.73 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2NPC1HPGDCRHBP
SCHEMBL10523694 0.73 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2NPC1HPGDCRHBP
SCHEMBL9591911 0.72 GAA (0.51) RAB9AMAPTSMN1; SMN2GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081513-A1 PRODRUGS OF KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2018-05-03 WO disclosed